Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06534320
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-26
Brief Title:
Safety Tolerability and Pharmacokinetic Characteristics Evaluation of DA-302168S Tablets
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase I Clinical Study to Evaluate the Safety Tolerability Pharmacokinetics Pharmacodynamics and Effects of Food in SingleMultiple Oral Administration of DA-302168S Tablets
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DA168
Brief Summary:
To Evaluate the Safety Tolerability and Pharmacokinetics on DA-302168S Tablets in Randomized Double-blind Placebo-controlled Single-dose and Multiple-dose ascending Phase I Clinical Trials in Healthy Subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None